Clinical trial
The Use of GnRH Agonist Trigger in the Prevention of OHSS
NCT00349258 · University of Connecticut, Other · Completed
Key facts
| NCT number | NCT00349258 |
|---|---|
| Title | The Use of GnRH Agonist Trigger in the Prevention of OHSS |
| Official title | A Prospective Randomized Study Comparing the Use of hCG or GnRH Agonist to Trigger Final Oocyte Maturation in High Responders Undergoing in-Vitro Fertilization Treatment |
| Lead sponsor | University of Connecticut, Other |
| Collaborators | Organon Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Ovarian Hyperstimulation Syndrome |
| Intervention type | Drug |
| Interventions | Leuprolide acetate |
| Enrollment | 66 |
| Start date | Aug 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Jul 6, 2006 |
| Last update posted | Jul 6, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: